Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How to treat women with antiphospholipid antibodies in pregnancy?

× No keyword cloud information.

32 in total

1. Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group.

Authors: E N Harris
Journal: Am J Clin Pathol Date: 1990-10 Impact factor: 2.493

2. Interlaboratory variation in antiphospholipid antibody testing.

Authors: A M Peaceman; R K Silver; S N MacGregor; M L Socol
Journal: Am J Obstet Gynecol Date: 1992-06 Impact factor: 8.661

3. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.

Authors: F S Cowchock; E A Reece; D Balaban; D W Branch; L Plouffe
Journal: Am J Obstet Gynecol Date: 1992-05 Impact factor: 8.661

4. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.

Authors: D W Branch; A M Peaceman; M Druzin; R K Silver; Y El-Sayed; R M Silver; M S Esplin; J Spinnato; J Harger
Journal: Am J Obstet Gynecol Date: 2000-01 Impact factor: 8.661

Review 5. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors: P E Love; S A Santoro
Journal: Ann Intern Med Date: 1990-05-01 Impact factor: 25.391

6. The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors: R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal: Medicine (Baltimore) Date: 1989-11 Impact factor: 1.889

7. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies.

Authors: H J Out; C D Kooijman; H W Bruinse; R H Derksen
Journal: Eur J Obstet Gynecol Reprod Biol Date: 1991-10-08 Impact factor: 2.435

How to treat women with antiphospholipid antibodies in pregnancy?

1. Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group.

2. Interlaboratory variation in antiphospholipid antibody testing.

3. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.

4. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.

Review 5. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

6. The "primary" antiphospholipid syndrome: major clinical and serological features.

7. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies.

8. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.

9. Fetal survival after prednisone suppression of maternal lupus-anticoagulant.

Review 10. First-trimester ultrasonography findings in women with a history of recurrent pregnancy loss.

Review 1. Current treatment of antiphospholipid syndrome: lights and shadows.

Review 2. Management of the antiphospholipid syndrome.